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Abstract
Background: identiﬁcation of individuals with high fracture risk from within primary care is complex. It is likely that the
true contribution of falls to fracture risk is underestimated.
Methods: cross-sectional analysis of a population-based cohort of 3,200 post-menopausal women aged 73±4 years.
Self-reported data were collected on fracture, osteoporosis clinical risk factors and falls/mobility risk factors. Self-reported
falls were compared with recorded falls on GP computerised records. Multivariable logistic regression was used to identify
independent risk factors for fracture.
Results: a total of 838 (26.2%) reported a fracture after aged 50; 441 reported falling more than once per year, but 69% of
these had no mention of falls on their computerised GP records. Only age [odds ratios (OR): 1.37 per 5 year increase, 95%
conﬁdence interval (CI): 1.23–1.53], height (1.02 per cm increase, 95% CI: 1.01–1.04), weight (OR: 0.99 per kg increase,
95% CI: 0.98–0.99) and falls (OR: 1.49 for more than once per year compared with less, 95% CI: 1.13–1.94) were inde-
pendent risk factors for fracture. Falls had the strongest association.
Conclusion: when identifying individuals with high fracture risk we estimate that more than one fall per year is at least
twice as important as height and weight. Furthermore, using self-reported falls data is essential as computerised GP
records underestimate falls prevalence.
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Osteoporosis is one of the commonest diseases to affect
the elderly, and by the year 2050 the number of men and
women estimated to be affected will be more than 30
million in the EU [1]. The consequences of osteoporosis
are bone fractures resulting in morbidity, reduced quality of
life and mortality. If an individual is identiﬁed as being at
high risk of osteoporotic fracture, bone-protective medica-
tion is available such as bisphosphonates, which reduce the
risk of future fracture by approximately 50% [2].
However, assessing an individual’s fracture risk is complex.
Despite the established inverse relationship between bone
mineral density (BMD) and fracture, approximately half of
hip fractures occur in women whose BMD is above the
osteoporotic threshold [3]. A range of clinical risk factors are
also informative, as used by the WHO fracture prediction
tool FRAX [4].FRAX provides an estimate of risk of hip and
other osteoporotic fractures over the following 10 years. The
clinical risk factors it incorporates were chosen from the
results of meta-analyses [5, 6] and include age, body mass
index (BMI) [7], glucocorticoids [8], previous fractures [9],
family history of hip fracture [10], smoking [11], alcohol
intake [12] and secondary causes of osteoporosis.
One limitation of FRAX is that it does not include falls
or mobility which are noteworthy determinants of fracture
risk [13]. There is increasing evidence for the efﬁcacy of
multidisciplinary interventions in reducing fracture risk by a
reduction in falls [14]. An analysis of a Swedish community-
based intervention aimed at preventing falls suggests it may
be as cost-effective as bone-protective therapy in the preven-
tion of hip fractures [15]. At least two previous studies have
found that a history of falls predict fractures independently
of other risk factors such as those included in FRAX, and
that integration of this information may enable more accurate
prediction of fractures [16, 17]. Since both studies used data
from computerised General Practice records [The Health
Improvement Network (THIN) database and QResearch
database] rather than self-reported data, the true rate of vari-
ables such as falls may have been underestimated.
In the present study, we aimed to investigate the relative
strength of associations between conventional risk factors
for osteoporosis or risk factors related to falls and mobility
and overall fracture risk, based on self-reported data as
opposed to computerised GP records.
Methods
Study design
Cross-sectional analysis of a large population-based cohort
study of post-menopausal women.
Study population
The Cohort for Skeletal Health in Bristol and Avon
(COSHIBA) is a population-based cohort of 3,200 women
with a date of birth between 1 January 1927 and 31
December 1942 from South-West England. Women were
invited to take part with the only entry criterion a date of
birth within the required range. For further details about re-
cruitment and representative nature see Supplementary data
Appendix 1 in Age and Ageing online. Data were collected
from the participants on entry to the study by self-
completion questionnaires after obtaining written consent.
For details of questionnaire please see Supplementary Data
Appendix 2 in Age and Ageing online. Ethical approval was
obtained from the Gloucestershire Research Ethics
Committee (REC 07/Q2005/47).
Outcome measure: reported fractures
Data were collected on self-reported fractures since aged 50
years. A random 5% subsample of reported fractures were
veriﬁed against GP records: 79.5% of reported fractures
were conﬁrmed, similar to that found by other researchers
[18]. Data were also collected on the mechanism of injury,
allowing classiﬁcation by the researchers based on descrip-
tion of the injury into slight/low or other trauma, based on
the modiﬁed-Landin descriptions [19].
Exposure measures: clinical risk factors
Self-reported data were collected on various clinical risk
factors for fracture. To validate this self-reported data a
random 5% subsample (n = 150) of COSHIBA partici-
pants had their self-completed baseline questionnaires com-
pared with their electronic GP records. For further details
see Supplementary Data Appendix 3 in Age and Ageing
online.
Age: calculated from date of birth.
Height and weight: self-reported.
Parental hip fracture: self-reported history of maternal hip
fracture.
Current smoking: self-reported smoking, where non- and
ex-smokers were grouped together.
Use of glucocorticoids: self-reported use of oral steroids
for more than 3 months as an adult.
Secondary causes of osteoporosis: self-reported history of
secondary causes of osteoporosis over the previous 2
years: Cushings disease, hyperparathyroidism, epilepsy,
Crohn’s disease, ulcerative colitis, polymyalgia rheumatica
and multiple sclerosis. Self-report of rheumatoid arthritis
and hyperthyroidism was not used because of poor
validity.
Alcohol intake of 3 or more units per day: self-reported
alcohol intake of at least one drink per day.
Previous fracture: self-reported fractures occurring during
adult life (aged 18–50), arising from slight trauma as
used in FRAX.
Exposure measures: falls/mobility
Fall frequency: participants were asked about the number
of falls they had experienced over the last 5 years. Falls
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Cross-sectional analysis of COSHIBAwere divided into a binary variable of a fall frequency of
more than once a year compared with less.
Mobility: self-reported furthest walking distance of less
than 400 yards was classiﬁed as a risk factor.
Use of a walking aid: self-reported use of any walking
aid either sometimes or regularly was classed as a risk
factor.
Data management and statistical analysis
The outcome measure was reported fractures since aged
50. With our sample size and assuming an α-level error
of 5% we have greater than 80% power to identify a 5%
difference between those with and without fracture after
50. Logistic regression was used to calculate odds ratios
(OR) and 95% conﬁdence intervals (CI) to describe the
association between risk factors and presence or absence
of reported fracture since aged 50. To look for independ-
ent associations with fracture risk, all variables were
included in the ﬁnal multivariable logistic regression ana-
lysis. To assess the additional predictive ability of includ-
ing falls with clinical risk factors, the pseudo R
2 and
Chi-squared values were visually compared—larger values
indicate better predictive ability, and the likelihood ratio
test (LRT) was used to assess if the difference seen
could have occurred by chance. Furthermore, a Fit
Statistic (AIC, Akaike’s Information Criterion) was calcu-
lated for the logistic regression model, introducing the
clinical risk factors in a stepwise fashion. AIC indicates
the goodness of ﬁt of the model with lower values indi-
cating better ﬁt. A Scree Plot was then drawn to show
the change in AIC with each additional risk factor in an
attempt to quantify the additional beneﬁt of falls/mobility
clinical risk factors. Risk factors were added in differing
orders based on investigator choice to check for robust-
ness of the change in AIC on adding falls to the model
predicting fractures. Participants with missing data were
excluded from relevant analyses.
....................................................................................
Table 1. Clinical risk factors and falls/mobility risk factors in those with and without reported fracture after aged 50





With fracture No fracture
nn
Clinical risk factors
Age 838 2,361 73.5 (4.4) 72.4 (4.2) <0.001
Height (cm) 740 2,115 160.3 (6.8) 160.1 (6.4) 0.513
Weight (kg) 796 2,245 69.2 (13.4) 69.5 (13.2) 0.520
nn n (%) n (%)
Maternal hip fracture
No 826 2,324 669 (81.0) 1,831 (78.8) 0.205
Yes 79 (9.6) 275 (11.8)
Unknown 78 (9.4) 218 (9.4)
Current smoking
No 827 2,327 763 (92.3) 2,149 (92.4) 0.934
Yes 64 (7.7) 178 (7.7)
Steroids >3 months
No 784 2,241 714 (91.1) 2,060 (91.9) 0.457
Yes 70 (8.9) 181 (8.0)
Secondary causes
a
No 836 2,348 782 (93.5) 2,193 (93.4) 0.887
Yes 54 (6.5) 155 (6.6)
Excess alcohol
No 827 2,333 727 (87.9) 2,035 (87.2) 0.612
Yes 100 (12.1) 298 (12.8)
Previous fractures aged 18–50
No 838 2,361 787 (93.9) 2,250 (95.3) 0.116
Yes 51 (6.1) 111 (4.7)
Falls/mobility risk factors
Fall frequency
Less than once per year 805 2,263 659 (81.9) 1,968 (87.0) <0.001
More than once per year 146 (18.1) 295 (13.0)
Mobility
Walking distance >400 yards 816 2,274 608 (74.5) 1,769 (77.8) 0.056
Walking distance <400 yards 208 (25.5) 505 (22.2)
Use of walking aid
No 831 2,315 627 (75.5) 1,857 (80.2) 0.004
Yes 204 (24.6) 458 (19.8)
aSecondary causes encompass self-reported Cushings disease, hyperparathyroidism, epilepsy, Crohn’s disease, ulcerative colitis, polymyalgia rheumatica and multiple
sclerosis.
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Of a total of 8,224 eligible women, 7,080 were invited from
15 general practices, and 3,200 (45.2%) enrolled. Similar to
all studies where a representative sample has been
attempted, COSHIBA has a shortfall in less afﬂuent partici-
pants (see Supplementary data Appendix 1 in Age and
Ageing online). The mean age of the cohort was 72.7±4.3
years (95% range from 66.6 to 79.9 years), and 838
(26.2%) reported a fracture after aged 50. Of these, 420
(50.1%) reported an upper limb fracture, 262 (31.3%) lower
limb and 80 (9.6%) reported both. Out of the entire
cohort, 441 (14.4%) of women reported falling a few times
a year or more (i.e. more than once per year). A random
5% subsample were veriﬁed against GP records and 69.2%
of those reporting falling more than once per year had no
falls recorded on the computerised GP records, suggesting
that these electronic records underestimate the true preva-
lence of falls.
Those with reported fracture after aged 50 were older
(73.5±4.4 years versus 72.4±4.2), had more falls (18.1%
fell more than once per year versus 13.0%) and were more
likely to use a walking aid (24.6% versus 19.8%) compared
with those without fracture. No other clinical or falls/mo-
bility risk factors differed between the two groups
(Table 1), although there was a suggestion that women with
reduced mobility were more likely to have a fracture
(P = 0.056).
Using a model with just the clinical variables, only age
(OR: 1.40 per 5-year increase, 95% CI: 1.26–1.57), height
(OR: 1.02 per cm increase, 95% CI: 1.01–1.04) and use of
steroids for more than 3 months (OR: 1.47, 95% CI: 1.04–
2.06) were independently associated with fractures. Similar
analyses were carried out for the falls/mobility risk factors
and only falls was an independent falls/mobility risk factor
(OR: 1.47 for more than once per year, 95% CI: 1.13–
1.91). Similar results were seen after limiting analyses to
those with low trauma fractures, and after dropping rare
falls (results not shown).
When combining all clinical and falls/mobility risk
factors (Table 2) only age (OR: 1.37 per 5-year increase,
95% CI: 1.23–1.53), height (1.02 per cm increase, 95% CI:
1.01–1.04), weight (OR: 0.99 per kg, 95% CI: 0.98–0.99)
and falls (OR 1.49 more than once per year, 95% CI:
1.13–1.94, P = 0.004) were independent risk factors.
Replacing height and weight with BMI did not change the
results.
To assess which variables were most strongly associated
with reported fracture after aged 50, we looked at the
pseudo-R
2. In our model just containing the clinical risk
factors this was 0.0189, whereas addition of the falls/mo-
bility risk factors increased this to 0.0231 showing that
more of the variance in fracture risk was explained by add-
ition of falls. The LRT test indicated this improvement was
unlikely to have occurred by chance (P < 0.001). To esti-
mate quantiﬁcation of the additional predictive ability of
adding falls to the clinical risk factor model we looked at
the AIC (Figure 1) which shows the biggest improvement
in the model with the addition of falls, suggesting it is a
stronger risk factor than age, height or weight. This was in-
dependent of the order in which the variables were
introduced.
Discussion
Our results suggest that in the UK primary care-based
population of older women, self-reported falls has the
strongest association with self-reported fracture. Our Scree
Plot suggests that reported falls explains the most variance
in reported fractures, and it is at least twice as important as
the other risk factors. As far as we are aware, this is the
ﬁrst report of the beneﬁts, and quantiﬁcation, of the
........................................
Table 2. Independent association between clinical and
falls/mobility-related risk factors and fractures in this
population of 2,424 elderly women
Risk factor OR for fracture risk adjusted for





Age (per 5 years) 1.37 (1.23–1.53) <0.001
Height (per cm) 1.02 (1.01–1.04) 0.005
Weight (per kg) 0.99 (0.98–0.99) 0.021









Steroids for >3 months
No 1.0 0.062
Yes 1.39 (0.99–1.98)



























Cross-sectional analysis of COSHIBAaddition of falls to the list of clinical risk factors using self-
reported data, and suggests that previous analyses using
computerised GP records have underestimated the import-
ance of falls in fracture prediction.
The prospective cohort study of 366,104 women using
the THIN database [16] reported age, previous fracture,
falls, BMI, smoking, any chronic disease diagnosis, and
recent use of central nervous system medications, as charac-
teristics that independently contributed to fracture risk at
any site. However, in this paper, relative weights given to
each risk factor show that for hip fractures for example,
age was the most important determinant followed by falls,
which agrees with the results of our study. Our study was
unable to identify the other risk factors found in THIN
and QResearch [17] that add small additional predictive
abilities, as we were only powered to ﬁnd strong risk
factors. However, in the THIN study [16], a simple scheme
that only included age and weight found fracture risks
similar to their more complex scheme. It is likely that falls
did not add a large additional beneﬁt to age and weight, as
seen in our study, because of lack of recording of falls on
GP medical records. Our results support the view that in
fallers, fracture prediction tools which take into account a
falls history may have advantages over the FRAX tool
which currently does not incorporate falls [20].
We also showed, in agreement with all other studies,
that age is the most important risk factor for fracture,
despite the fact that age varied over a relatively narrow
range in this study. Furthermore, we showed that height
was associated with reported fractures, with taller women
more likely to fracture. This has been shown previously for
hip fracture [21] with the explanation suggested involving
biomechanical parameters of hip axis length [22]. This is
unlikely to be the explanation of the association with frac-
tures in our cohort, as most were of the upper limb. It is
possibly more to do with falling from a greater height, and
a greater impact due to greater velocity, again reinforcing
the importance of falls. Many other studies, using patient
groups other than primary care-based populations agree
with our results that low weight is an important predictor
of fracture risk [23, 24], but we extend these results to
suggest that falls is more important.
It is interesting that our results conﬁrm that although
age and height/weight are important risk factors for frac-
ture risk, there was little evidence that other clinical risk
factors used in FRAX such as previous or family history of
fracture were associated with fractures. This is most likely
to be because we were only powered to ﬁnd strong risk
factors. Other explanations include differences in the study
population and methods of data collection. For example,
studies used in the FRAX meta-analyses were prospective
cohorts, while ours employed a cross-sectional analysis,
suggesting that our data may be less robust.
Being a cross-sectional analysis means our study will
suffer from bias, confounding and chance, and could be
explained by reverse causality. In particular, the reported
falls may predate the reported fracture. Nonetheless our
study utilised a population-based cohort of elderly women
from primary care and is roughly representative of the local
area. Our response rate of 45.2%, while initially appearing
Figure 1. A scree plot to show which clinical risk factors are the most important in determining fracture risk in this cohort. The
plot shows change in goodness of ﬁt with each additional clinical risk factor. Goodness of ﬁt of the models is shown on the
y-axis by AIC values where lower levels indicate better ﬁt. The x-axis shows the clinical risk factors included in the models. The
simplest model just contains age. All other clinical risk factors were added in a stepwise fashion such that the last model on the
right-hand side contains all risk factors.
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ment strategy [25]. Alternative explanations for our ﬁnding
that 69% of frequent fallers had no record of this with
their GP could include false positive reporting by study
participants, but we think this is unlikely.
A further limitation is the use of reported rather than veri-
ﬁed fractures as the main outcome. This will reduce the
strength of any association found, but is unlikely to be a
source of bias. We were unable to include rheumatoid arthritis
as a secondary cause of osteoporosis due to poor validity and
this is likely to have reduced the strength of any potential as-
sociation between secondary causes and fractures in our ana-
lysis. There is a concern that people are far more likely to
remember falls where they injured themselves such as fractur-
ing a bone, resulting in recall bias. Furthermore, there is the
potential for a large temporal difference between fractures
since aged 50 and reported falls over the past 5 years which
may introduce bias. The estimation of quantiﬁcation of the
additional predictive ability of adding falls to the clinical risk
factor model using a Fit Statistic isn’t ideal, as this penalises
models with increasing numbers of variables.
So in conclusion, our study has shown that age and falls
are the most important risk factors for fracture. We esti-
mate that a history of more than one fall per year is at least
twice as important as height or weight. Furthermore, using
self-reported falls data are essential as computerised GP
records underestimate falls prevalence. A risk-factor assess-
ment just using age and falls is likely to be a useful means
for simple fracture risk assessment for women within
primary care in the UK.
Key points
￿ In post-menopausal women from primary care, age and
falls are the strongest risk factors for fracture.
￿ Falling more than once per year is at least twice as im-
portant as other risk factors for fracture.
￿ Use of self-reported falls data is essential as computerised
GP records underestimate the prevalence of falls in post-
menopausal women.
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Abstract
Background: dementia is one of the main challenges to our health and social care. This study compares the number and
timing of transitions between care settings in the last 2 years of life among older people with and without dementia.
Methods: data were derived from Finnish national registers, and include all those who died in 2002 and 2003 at
the age of 70 or older (n = 70,366). Negative binomial regression analyses were used to analyse the impact of dementia
on number of transitions among people with and without dementia and to adjust the number for age, gender and other
diagnoses.
Results: in the group that lived at home 2 years before death people with a dementia diagnosis had 32% more care transi-
tions than people without dementia, while the group that was in residential care facility 2 years before death people with de-
mentia had 12% fewer moves than those without dementia The average number of transition was highest in last 3 months
of life. People with dementia had their last move more often between care facilities and hospitals offering basic health care
than people without dementia.
Conclusion: dementia has a signiﬁcant impact on the number and type of transitions. As the number of people with de-
mentia increases, the quality and equity of care of these patients in their last years constitute a special challenge.
Keywords: dementia, care transition, end-of-life care, ageing
Introduction
In the next decades the incidence of Alzheimer’s disease
and other dementias will increase with the increasing
number of older people [1]. Dementia is a signiﬁcant cause
of institutionalisation [2], disability and mortality [3]. In de-
mentia, as in other serious conditions, the greatest need for
care usually concentrates on the last years of life. During
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